AU2704984A – Hla d typing assay
– Google Patents
AU2704984A – Hla d typing assay
– Google Patents
Hla d typing assay
Info
Publication number
AU2704984A
AU2704984A
AU27049/84A
AU2704984A
AU2704984A
AU 2704984 A
AU2704984 A
AU 2704984A
AU 27049/84 A
AU27049/84 A
AU 27049/84A
AU 2704984 A
AU2704984 A
AU 2704984A
AU 2704984 A
AU2704984 A
AU 2704984A
Authority
AU
Australia
Prior art keywords
hla
assay
lymphocytes
phenotype
antigen
Prior art date
1983-04-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27049/84A
Other versions
AU583471B2
(en
Inventor
Elaine C. Defreitas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1983-04-19
Filing date
1984-04-18
Publication date
1984-10-25
1984-04-18
Application filed by Wistar Institute of Anatomy and Biology
filed
Critical
Wistar Institute of Anatomy and Biology
1984-10-25
Publication of AU2704984A
publication
Critical
patent/AU2704984A/en
1989-05-04
Application granted
granted
Critical
1989-05-04
Publication of AU583471B2
publication
Critical
patent/AU583471B2/en
2004-04-18
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 – G01N31/00
G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
G01N33/56966—Animal cells
G01N33/56977—HLA or MHC typing
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 – G01N31/00
G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
G01N33/56966—Animal cells
G01N33/56972—White blood cells
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
A61K2039/515—Animal cells
A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S435/00—Chemistry: molecular biology and microbiology
Y10S435/8215—Microorganisms
Y10S435/948—Microorganisms using viruses or cell lines
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S436/00—Chemistry: analytical and immunological testing
Y10S436/804—Radioisotope, e.g. radioimmunoassay
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S436/00—Chemistry: analytical and immunological testing
Y10S436/811—Test for named disease, body condition or organ function
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S436/00—Chemistry: analytical and immunological testing
Y10S436/815—Test for named compound or class of compounds
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S436/00—Chemistry: analytical and immunological testing
Y10S436/823—Immunogenic carrier or carrier per se
Abstract
An assay for HLA D phenotype wherein antigen-pulsed monocytes are contacted with antigen-specific T lymphocytes or T cell hybridomas and the extent of selective binding between the pulsed monocytes and the T lymphocytes or T cell hybridomas determines HLA D phenotype of the monocyte. The assay is particularly useful for quickly typing donortissue prior to transplantation.
AU27049/84A
1983-04-19
1984-04-18
Hla d typing assay
Ceased
AU583471B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US06/486,441
US4492760A
(en)
1983-04-19
1983-04-19
HLA D Typing assay
US486441
1983-04-19
Publications (2)
Publication Number
Publication Date
AU2704984A
true
AU2704984A
(en)
1984-10-25
AU583471B2
AU583471B2
(en)
1989-05-04
Family
ID=23931898
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU27049/84A
Ceased
AU583471B2
(en)
1983-04-19
1984-04-18
Hla d typing assay
Country Status (8)
Country
Link
US
(1)
US4492760A
(en)
EP
(1)
EP0123527B1
(en)
JP
(1)
JPS6069553A
(en)
AT
(1)
ATE49659T1
(en)
AU
(1)
AU583471B2
(en)
CA
(1)
CA1226218A
(en)
DE
(2)
DE123527T1
(en)
NZ
(1)
NZ207919A
(en)
Families Citing this family (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4582788A
(en)
*
1982-01-22
1986-04-15
Cetus Corporation
HLA typing method and cDNA probes used therein
DE3545576A1
(en)
*
1985-11-28
1987-07-02
Behringwerke Ag
HLA-B 27, DAFUER CODING GENOMIC DNA AND THEIR USE
DE69233468T3
(en)
*
1991-01-21
2011-05-05
Elan Pharmaceuticals, Inc., San Francisco
TEST AND MODEL FOR ALZHEIMERS DISEASE
US5604102A
(en)
*
1992-04-15
1997-02-18
Athena Neurosciences, Inc.
Methods of screening for β-amyloid peptide production inhibitors
US5441870A
(en)
*
1992-04-15
1995-08-15
Athena Neurosciences, Inc.
Methods for monitoring cellular processing of β-amyloid precursor protein
US6610493B1
(en)
1993-06-17
2003-08-26
Brigham And Women’s Hospital
Screening compounds for the ability to alter the production of amyloid-β peptide
ES2225824T3
(en)
*
1992-08-31
2005-03-16
Ludwig Institute For Cancer Research
ISOLATED NONAPEPTIDE DERIVED FROM GEN MAGE-3 AND PRESENTED BY HLA-A1, AND ITS USES.
US5605811A
(en)
*
1992-10-26
1997-02-25
Athena Neurosciences, Inc.
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
PT730643E
(en)
1993-10-27
2001-06-29
Lilly Co Eli
APP TRANSPORTATION ALGE TRANSGENIC ANIMALS WITH SWEDISH MUTACAO
US6717031B2
(en)
1995-06-07
2004-04-06
Kate Dora Games
Method for selecting a transgenic mouse model of alzheimer’s disease
Family Cites Families (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
CA1086646A
(en)
*
1976-06-17
1980-09-30
Marilyn L. Bach
Primed leukocyte typing
US4265873A
(en)
*
1976-06-18
1981-05-05
Wisconsin Alumni Research Foundation
Method for typing human leukocyte antigens
SE429254B
(en)
*
1979-02-27
1983-08-22
Henry Johansson
DEVICE FOR FORMATING SMALL VOLUMES OF WETS IN A MAJORITY PARALLEL FLEXIBLE HOSE
US4318886A
(en)
*
1979-11-19
1982-03-09
Nippon Kogaku K.K.
Automatic HLA typing apparatus
US4314026A
(en)
*
1980-03-31
1982-02-02
Institut National De La Sante Et De La Recherche Medicale
Process for determining the complement-dependent cytotoxicity mediated by anti-HLA antibodies by means of ATP determination and device for ATP determination
DE3381518D1
(en)
*
1982-01-22
1990-06-07
Cetus Corp
METHOD FOR CHARACTERIZING HLA AND THE CDNS TEST AGENTS USED IN IT.
1983
1983-04-19
US
US06/486,441
patent/US4492760A/en
not_active
Expired – Fee Related
1984
1984-04-18
CA
CA000452312A
patent/CA1226218A/en
not_active
Expired
1984-04-18
AU
AU27049/84A
patent/AU583471B2/en
not_active
Ceased
1984-04-19
DE
DE198484302680T
patent/DE123527T1/en
active
Pending
1984-04-19
NZ
NZ207919A
patent/NZ207919A/en
unknown
1984-04-19
AT
AT84302680T
patent/ATE49659T1/en
not_active
IP Right Cessation
1984-04-19
JP
JP59079330A
patent/JPS6069553A/en
active
Pending
1984-04-19
DE
DE8484302680T
patent/DE3481085D1/en
not_active
Expired – Fee Related
1984-04-19
EP
EP84302680A
patent/EP0123527B1/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
DE3481085D1
(en)
1990-02-22
ATE49659T1
(en)
1990-02-15
EP0123527A2
(en)
1984-10-31
AU583471B2
(en)
1989-05-04
US4492760A
(en)
1985-01-08
EP0123527A3
(en)
1985-12-18
DE123527T1
(en)
1985-05-23
NZ207919A
(en)
1988-02-29
EP0123527B1
(en)
1990-01-17
JPS6069553A
(en)
1985-04-20
CA1226218A
(en)
1987-09-01
Similar Documents
Publication
Publication Date
Title
EP0138833A4
(en)
1987-12-09
Cell viability assay methods and apparatus.
AU3298784A
(en)
1985-06-27
Cooling system for electrochemical fuel cell
DK496085A
(en)
1986-05-01
SPACE CELL CULTIVATION DEVICE AND PROCEDURE FOR CULTURING CELLS
AU583471B2
(en)
1989-05-04
Hla d typing assay
GB2150326B
(en)
1987-04-23
Voice/text storage and retrieval system
GR3035603T3
(en)
2001-06-29
Mammals lacking expression of cd28 transgenic
GB8724543D0
(en)
1987-11-25
Demonstrating & studying operation of fuel cell
AU6743287A
(en)
1987-07-23
Membrane cell culture device
ZA817158B
(en)
1983-01-26
High temperature solid electrolyte fuel cell configurations and interconnections
DK0414475T3
(en)
1998-02-09
Methods for culturing HCV in B or T lymphocyte cell lines
AU1519488A
(en)
1988-11-03
Improved solid electrolyte fuel cell and assembly
ZA812050B
(en)
1982-06-30
Fuel cell system configurations
EP0159044A3
(en)
1987-09-16
Process for semen separation
ZA812773B
(en)
1982-04-28
Method for the immunological determination of enzymes, means for carrying out the method, and its use
EP0217992A3
(en)
1989-05-24
Lysing or blocking unwanted cells
SG86984G
(en)
1985-06-07
System for the rapid transmission of messages between computers
AU6429186A
(en)
1987-04-30
Cell culturing device
AU2544384A
(en)
1984-09-13
Electrochemical cell membrane
AU550146B2
(en)
1986-03-06
Single cell protein from sulfur energy sources
AU3635484A
(en)
1985-06-27
Haul and launch hydrofoils
AU2095992A
(en)
1994-03-24
Flow cytometry sheath reagent for elimination of red cells with preservation of nucleated cells
AU580949B2
(en)
1989-02-09
Cell culture apparatus and process using an immobilized cell composite
JPH0588115B2
(en)
1993-12-21
MX9273A
(en)
1993-10-01
PROCEDURE FOR THE PREPARATION OF MONOCLONAL ANTIBODIES NEGATIVE ANTIGRAM AND CELL LINE WITH BIOLOGICAL ACTIVITY
NZ256776A
(en)
1997-10-24
Transgenic mammalian cells containing a dna sequence expressing pghs-2
None